Citizens sells liquefied natural gas unit to equity firm
A five-year-old Indianapolis company that supplies liquefied natural gas to trucking companies, manufacturers and other customers is now under new ownership.
John Russell
Articles
Lilly buying developer of pain-management drugs for $960M
The Indianapolis-based drugmaker’s purchase of the biotech firm CoLucid Pharmaceuticals will give it access to a late-stage experimental medication for migraine headaches.
Bill would let hospitals require flu vaccinations for clinical workers
A similar bill was waylaid last year in the Indiana General Assembly after objections from some health care workers. Now, another effort is under way.
Which physician specialties have the worst burnout?
Doctors are reporting more burnout because of too many bureaucratic tasks, difficult patients and too many hours at work. But not all specialties are hit equally hard.
Community Health demolishing, rebuilding East hospital
The wrecking ball is busy at Community Hospital East, knocking down one building after another, as workers ready the site for a brand-new, $175 million hospital.
Carmel biotech firm scores major deal with pharmaceutical giant
A small Carmel-based biotech firm has signed a deal with international drug company Allergan Plc that is worth at least $50 million and could grow to more than $2 billion under the best-case scenario.
Indiana lawmakers take up wide range of health care legislation
The Indiana General Assembly is back in session and set to consider all manner of health care legislation, from consumer rights to expanded insurance coverage.
Closing IPL’s toxic ponds could cost millions
As IPL ditches coal in favor of natural gas at power plants in Indianapolis and Martinsville, the utility wants to close their coal ash pits, cover the tops with plastic membranes, and top them off with nearly three feet of sand and soil.
Atterholt wants job back on state utility board
Gov. Mike Pence’s chief of staff, who will lose his position when Pence leaves office on Monday, is seeking to return to the five-member state commission that oversees utilities.
Lilly exec Azar departs as new CEO makes organizational changes
Alex Azar, president of Lilly USA LLC since 2012, is leaving the company just as his unit is about to lose a huge swath of sales personnel. The drugmaker announced a series of changes Thursday under new CEO David Ricks.
Zoeller seeks to establish local unit of global trade group
Departing Indiana Attorney General Greg Zoeller wants to persuade the organization to add Indianapolis to its roster of world trade centers, hooking local firms into international business networks and encouraging imports and exports.
Riley Hospital expands ER to handle more mainstream patients
Riley is spending millions of dollars and beefing up its emergency staff to expand into traditional emergency services.
2016 TOP STORIES: Feds charge nursing home executives with fraud
Federal prosecutors say two American Senior Communities executives and two other men orchestrated a scheme that used kickbacks and shell companies to defraud American Senior Communities and federal health care programs out of millions of dollars.
2016 TOP STORIES: Anthem-Cigna merger runs into big trouble
In July, the U.S. Department of Justice sued the two companies to keep them independent. A trial got underway in November with no end in sight.
2016 TOP STORIES: Micro- hospitals trend lands here
What’s driving the tiny hospitals here and around the country is cost. They’re often only 15,000 to 50,000 square feet in size and cost only $7 million to $30 million to build.
2016 TOP STORIES: Lilly Alzheimer’s drug fails in high-stakes trial
t was the most closely watched experimental drug from Eli Lilly and Co. in years, a potential game-changer for treating the ravages of Alzheimer’s disease.
Indiana edges up to 39th place in national health rankings
The Hoosier state still has an armful of health challenges, from high levels of smoking and obesity to the prevalence of air pollution and cardiovascular disease.
Lawsuit throws spotlight on chaos surrounding Anderson cardiology practice
The “toxic” office environment at a small St. Vincent Health office had broken out during an unprecedented wave of acquisitions of physician practices in central Indiana.
Lilly trims profit guidance but says growth strategy on track
The company’s announcement reassured investors in the wake of last month’s news that the Alzheimer’s drug solanezumab had failed to demonstrate effectiveness during a large-scale clinical trial.
My body is the battleground between cancer and chemo
The point of chemo is to cure me. But these are not gentle chemicals. They sweep through my body like a tornado, with side effects that range from annoying to horrendous. But I have no choice.